1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Michael John Robertson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant Human IL-18 and Ofatumumab After PBSCT for Lymphoma Ofatumumab combined with SB-485232 - Non-Hodgkin's Lymphoma | Phase 1 | Completed | Michael John Robertson | 9 | 2013-02-01 | 2023-02-10 |
Interleukin-18 (1)
United States (1)